Patent · US Active

Engineered antibodies and other Fc-domain containing molecules with enhanced agonism and effector functions

US10669344B2 · kind B2 · utility

0Cited by
14References
20Claims
0Family size

Assignee

Inventors

Key dates

Filing dateJul 28, 2017
Grant dateJun 2, 2020
Priority date—
Expiry dateJul 28, 2037

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC07K2319/30
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

The present invention relates to engineered antibodies and other Fc-domain containing molecules with enhanced agonism and effector functions.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.